Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Panacos Pharmaceuticals
company
About
Panacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases.
- 11 - 50
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The companys discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$38.30M
Panacos Pharmaceuticals has raised a total of
$38.30M
in funding over 2 rounds. Their latest funding was raised on
Jun 28, 2007 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 28, 2007 | Post-IPO Debt | $20M | 1 |
Hercules Capital
|
— | Detail |
| May 18, 2004 | Post-IPO Equity | $18.30M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Panacos Pharmaceuticals is funded by 3 investors.
Hercules Capital
and Maryland Department of Business and Economic Development
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
Maryland Department of Business and Economic Development
|
— | Post-IPO Equity |
New England Partners
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
